Skip to main content
Prof Aaron Sverdlov
Co-Director
LinkedIn
ORCID
Back to Team

Prof Aaron Sverdlov

MBBS, PhD, FRACP, FCSANZ, FESC, FHFA, FACC, FICOS

Professor Aaron Sverdlov is a cardiologist and clinician-scientist specialising in heart failure and cardio-oncology. He is Professor at the University of Newcastle, Senior Cardiologist with Hunter New England Health, Director of Heart Failure, and Clinical Lead for Heart Failure and Cardio-Oncology.

Together with Professor Doan Ngo, Aaron founded and co-leads Newcastle’s cardio-oncology and heart failure clinical and research programs, bringing together specialist clinical care, discovery science, translational research and clinical studies. The Newcastle Centre of Excellence in Cardio-Oncology was the first Australian cardio-oncology program to achieve Gold Tier Centre of Excellence accreditation from the International Cardio-Oncology Society.

His research focuses on understanding, preventing and treating cardiovascular complications of cancer and cancer therapy, as well as heart failure and cardiometabolic disease. A major emphasis is translating discoveries from the laboratory into new treatments and models of care, including cardioprotective therapies, cardiovascular risk prediction, survivorship and regional delivery of specialist care.

Current Roles

  • Professor, University of Newcastle
  • Senior Cardiologist, Hunter New England Health
  • Director of Heart Failure, University of Newcastle / Hunter New England Health
  • Clinical Lead, Heart Failure and Cardio-Oncology, Hunter New England Health
  • Co-Founder and Co-Director, Newcastle Centre of Excellence in Cardio-Oncology
  • Inaugural Chair, CSANZ Cardio-Oncology Committee
  • Board Director, International Cardio-Oncology Society
  • Member, ESC Council of Cardio-Oncology Study Group on Translational and Immune Cardio-Oncology
  • Associate Editor: Heart Failure Reviews, Heart Lung & Circulation
  • Editorial Board: European Heart Journal – Cardio-Oncology, Scientific Reports, Cardiovascular Drugs and Therapy
  • International Advisor, JACC: CardioOncology

Research Profile

  • More than 150 peer-reviewed publications
  • h-index 40
  • Approximately $24 million in career research funding as a Chief Investigator
  • Site Principal Investigator on 18 multicentre clinical trials
  • Five PhD completions since 2024, with four current PhD candidates
  • Former Heart Foundation Future Leader Fellow, NHMRC CJ Martin Fellow and American Heart Association Postdoctoral Fellow

Selected Recognition

  • HNELHD Staff Member of the Year, 2025
  • John Hunter Hospital Cardiovascular Medicine Senior Researcher of the Year, 2023–2026
  • Heart Lung and Circulation High Impact Award, 2025
  • HMRI Team Excellence Award, 2023
  • HNE Health Excellence Award for Integrated Value Care, 2023

Aaron is board-certified in cardio-oncology by the International Cardio-Oncology Society and is a Fellow of CSANZ, ESC, HFA, ACC and IC-OS.

Research Interests

Cardio-oncology · Heart failure · Cardioprotective therapies · Cancer survivorship and cardiovascular risk · Biomarkers and risk prediction · Clinical and translational research · Cardiometabolic disease · Regional and integrated models of cardiovascular care.

  1. Doi S, Kazui S, Akashi N, Patel RB, Komtebedde J, Mylavarapu U, Swarup V, Winkler S, Backhaus SJ, Litwin SE, Mohan RC, Kawash R, Sverdlov AL, Chung ES, Kaye DM, Hoendermis E, Hummel SL, Cikes M, Hayward CS, Starling R, Gupta DK, Zirlik A, McKenzie S, Nair A, Rieth A, Cutlip DE, Solomon SD, van Veldhuisen DJ, Leon MB, Silvestry FE, Shah SJ, Borlaug BA. Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF II. JACC Heart Fail. 2026 Jun 5:103167. doi: 10.1016/j.jchf.2026.103167. Epub ahead of print. PMID: 42268170.
  2. Albayati A, Butel-Simoes L, Gadre P, Goode G, Collins NJ, Sverdlov AL, Boyle AJ, Al-Omary MS. Frailty and Coronary Artery Disease: Proposed Pathophysiology and A Complex Interaction Influencing Management and Outcomes in Older Adults. Heart Lung Circ. 2026 Jun;35(6):763-777. doi: 10.1016/j.hlc.2026.05.002. Epub 2026 May 13. PMID: 42128755.
  3. Fakes K, Wetzler HF, Williams T, Collins N, Sverdlov AL, Hobden B, Boyle A. Challenges to Telehealth in Regional Areas: Cross-Sectional Survey Study of Cardiology Outpatients. Heart Lung Circ. 2026 May;35(5):e67-e71. doi: 10.1016/j.hlc.2025.12.021. Epub 2026 Apr 20. PMID: 42014293.
  4. Malaty MM, Trevaskis N, Govender K, Sverdlov AL, Wilsmore BR, Barlow M, Jackson N, Morris GM. Left Atrial Posterior Wall Functional Remodeling in Paroxysmal and Persistent Atrial Fibrillation. A Pilot Study. J Cardiovasc Electrophysiol. 2026 May;37(5):980-988. doi: 10.1111/jce.70320. Epub 2026 Mar 25. PMID: 41882991; PMCID: PMC13182214.
  5. Saraf K, Malaty M, Ferreira D, Govender K, Butel-Simoes L, Kaur A, Sverdlov A, Sanchez AP, Ha ACT, Chauhan V, D'Ambrosio P, Morris GM, Jackson N. Left atrial myopathy development and progression in atrial fibrillation patients with recurrent left atrial ablation procedures: the LAMP-AF study. Heart Rhythm. 2026 May 5:S1547-5271(26)02346-5. doi: 10.1016/j.hrthm.2026.04.056. Epub ahead of print. PMID: 42097250.
  6. Butel-Simoes LE, Bennetts JD, Croft A, Williams TD, Janowski W, Martin J, Lynam J, Ngo DT, Sverdlov AL. Integrated Cardio-oncology Service. Card Fail Rev. 2026 Apr 29;12:e09. doi: 10.15420/cfr.2025.44. PMID: 42110959; PMCID: PMC13153930.
  7. Busti M, Canonico ME, Keramida K, Palazzuoli A, Kato E, Sakata Y, Alexy T, Grupper A, Nodari S, Ojji DB, Sverdlov AL, Guimaraes PO, Musella F, Ambrosy AP, Girerd N, Monzo L. Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie. Heart Fail Rev. 2026 Apr 15;31(1):57. doi: 10.1007/s10741-026-10627-1. PMID: 41984352.
  8. Fraser Wetzler H, Boyle A, Hobden B, Sverdlov AL, Zwar N, Hungerford R, Collins N, Williams T, Paolucci F, Robson C, Fakes K. Participant experiences and engagement with the enhanced heart failure care program: a qualitative study. Health Psychol Behav Med. 2026 Apr 6;14(1):2654919. doi: 10.1080/21642850.2026.2654919. PMID: 41953282; PMCID: PMC13055023.
  9. Chen DH, Butel-Simoes L, Bower M, Nolan MT, Kumar SS, Williams TD, Koczwara B, Ell P, Bennetts JD, Nair GR, Lee J, Ramkumar S, Ngo DTM, Sverdlov AL. The Current Cardio-Oncology Landscape Across Australia. Curr Treat Options Oncol. 2026 Apr 18;27(1):22. doi: 10.1007/s11864-026-01390-4. PMID: 41999534; PMCID: PMC13091860.
  10. Avagimyan A, Pogosova N, Cardinale D, Fogacci F, Djndoyan Z, Mkrtchyan L, Rezabakhsh A, Cicero A, Faggiano A, Gherbesi E, Carugo S, Taheri M, Bernardi M, Spadafora L, Sasso LL, Perone F, Shafie D, Rizzo M, Alizadehasl A, Moudgil R, Sabouret P, Sverdlov AL, Prattichizzo F, Ceriello A, Biondi-Zoccai G, Madonna R, De Caterina R, Asteggiano R, Sarrafzadegan N. Diagnostics in cardio-oncology: a focus on anthracyclines. Heart Fail Rev. 2026 Mar 20;31(1):39. doi: 10.1007/s10741-026-10604-8. PMID: 41857312.
  11. Grupper A, Sverdlov AL, Cheema BS, Nasrollahizadeh A, Hosseini K. Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers. Heart Fail Rev. 2026 Mar 18;31(1):38. doi: 10.1007/s10741-026-10603-9. PMID: 41848906; PMCID: PMC12999815.
  12. Ferreira D, Dwivedi J, Brienesse S, Malaty MM, Govender K, Trevaskis N, Hughes B, Sverdlov AL, Collins N, Boyle A, Morris GM, Barlow M, Jackson N. Arctic Front Advance Versus POLARx Cryoablation System for Pulmonary Vein Isolation in Patients With Atrial Fibrillation: A Single-Center Randomized Controlled Trial. Circ Arrhythm Electrophysiol. 2026 Feb;19(2):e014446. doi: 10.1161/CIRCEP.125.014446. Epub 2026 Jan 23. PMID: 41574428.
  13. Herrmann J, Barac A, Carver J, Cheng RK, Daniele A, Dent S, Deych E, Lee DH, Lenihan D, Leong DP, Liu J, Lopez-Fernandez T, Lyon AR, Fradley M, Macedo AVS, Mooradian MJ, Nohria A, Porter C, Rassaf T, Suero-Abreu G, Sverdlov AL, Thavendiranathan P, Neilan TG, Mitchell JD. Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position Statement. JAMA Oncol. 2026 Jan 1;12(1):90-99. doi: 10.1001/jamaoncol.2025.4543. PMID: 41231466.
  14. Butel-Simoes LE, Albayati A, Yu J, Quirk T, Sritharan S, French M, Bennetts JD, Ngo DTM, Sverdlov AL. Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding. J Thromb Thrombolysis. 2026 Feb;59(2):393-410. doi: 10.1007/s11239-025-03151-w. Epub 2025 Sep 15. PMID: 40952587; PMCID: PMC13018079.
  15. Litwin SE, Komtebedde J, Borlaug BA, Kaye DM, Hasenfuβ G, Kahwash R, Hoendermis E, Hummel SL, Cikes M, Gustafsson F, Chung ES, Mohan RC, Sverdlov AL, Swarup V, Winkler S, Hayward CS, Bergmann MW, Bugger H, McKenzie S, Nair A, Rieth A, Burkhoff D, Cutlip DE, Solomon SD, van Veldhuisen DJ, Leon MB, Shah SJ. Corrigendum to "Long-term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials" [American Heart Journal (278)2024 Page Number:106-116]. Am Heart J. 2026 Mar;293:107312. doi: 10.1016/j.ahj.2025.107312. Epub 2025 Dec 18. Erratum for: Am Heart J. 2024 Dec;278:106-116. doi: 10.1016/j.ahj.2024.08.014. PMID: 41418529.
  16. Tocchetti CG, Farmakis D, Koop Y, Maria Sol Andres, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Rogiers A, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K; De Boer RA, Maack C, Lutgens E, Rassaf T, Fradley M, Moslehi J, Yang EH, De Keulenaer G, Ameri P, Bax J, Neilan TG, Herrmann J, Mbakwem AC, Mirabel M, Skouri H, Hirsch E, Cohen-Solal A, Sverdlov AL, van der Meer P, Asteggiano R, Barac A, Ky B, Lenihan D, Dent S, Seferovic P, Coats A, Metra M, Rosano G, Suter T, Lopez-Fernandez T, Lyon AR. Cardiovascular toxicities of immune therapies for cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail 2024; accepted; DOI: 10.1002/ejhf.3340.
  17. Ferreira D, Mikhail P, Lim J, Ray M, Dwivedi J, Brienesse S, Butel-Simoes L, Meere W, Bland A,  Howden N, Malaty M, Kunda M, Kelty A, McGee M, Boyle A, Sverdlov AL, William M, Attia J, Jackson N, Morris G, Barlow M, Leitch J, Collins N, Ford T, Wilsmore B. Manual Chest PRESSURE during Direct Current Cardioversion for Atrial Fibrillation: A Randomized Control Trial (PRESSURE-AF). JACC Clin Electrophysiol 2024; accepted.
  18. Gustafsson F, Petrie MC, Komtebedde J, Swarup V, Winkler S, Hasenfuß G, Borlaug BA, Mohan RC, Flaherty JD, Sverdlov AL, Fail PS, Chung ES, Lurz P, Lilly S, Kaye DM, Cleland JGF, Cikes M, Leon MB, Cutlip DE, van Veldhuisen DJ, Solomon SD, Shah SJ. Two-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results from REDUCE LAP-HF II. JACC Heart Fail 2024; accepted.
  19. Bennetts JD, Mahmud A, Yu J, Ngo DT, Sverdlov AL. From Signal to Care: Artificial Intelligence in Cardio-Oncology. Trends in cardiovascular medicine. 2026 Mar 25:S1050-1738.
  20. Bennetts JD, Robson C, Weismantel-Savage A, Mani J, Yu J, Robson L, Collins NJ, Williams TD, Sverdlov AL, Ngo DT. Evaluation of a Nurse-Pharmacist Post-Discharge Telehealth Model of Care for People With Heart Failure. Heart, Lung and Circulation. 2026 Mar 20.
  21. Bennetts JD, Sverdlov AL, Ngo DT. Cardiometabolic Perturbations Arising from Treatment with Novel Anticancer Therapies. Trends in Cardiovascular Medicine. 2025 Oct 25.
  22. Butel-Simoes LE, Albayati A, Yu J, Quirk T, Sritharan S, French M, Bennetts JD, Ngo DT, Sverdlov AL. Tyrosine kinase inhibitors-balancing the haemostatic scales: a review of associated thrombosis and bleeding. Journal of Thrombosis and Thrombolysis. 2025 Sep 15:1-8.
  23. Bennetts J, Robson C, Weismantel-Savage A, Mani J, Yu J, Robson L, Collins N, Williams T, Sverdlov A, Ngo D. Impact of a Nurse-Pharmacist Telehealth Model of Care on Hospital Readmissions and Prescribing of Guideline-Directed Medical Therapy for People With Heart Failure. Heart, Lung and Circulation. 2025 Aug 1;34:S308-9.
  24. Bennetts JD, Williams TD, Beavers CJ, Moore HN, Robson C, Warner T, Dent S, Sverdlov AL, Ngo DT. The cardio-oncology multidisciplinary team: beyond the basics. Cardio-oncology. 2025 Jul 26;11(1):69.
  25. Bennetts J, Robson C, Weismantel-Savage A, Mani J, Williams T, Sverdlov A, Ngo D. Feasibility and Acceptability of a Nurse-Pharmacist Post-Discharge Telehealth Model of Care for Heart Failure Patients. Circulation. 2024 Nov 12;150(Suppl_1):A4126893-.
  26. Bennetts J, Walker R, Williams T, Sverdlov A, Ngo D. Risk Factors Associated with Cardiac Hospital Admissions in Cancer Patients Treated with Immune Checkpoint Inhibitors. Circulation. 2024 Nov 12;150(Suppl_1):A4117414-.
  27. Bennetts J, Williams T, Walker R, Ngo D, Sverdlov A. Factors Associated With Cardiac Hospital Admissions in Cancer Patients Treated With Immune Checkpoint Inhibitors. Heart, Lung and Circulation. 2024 Aug 1;33:S299-300.
  28. Fakes K, Hobden B, Zwar N, Collins N, Oldmeadow C, Paolucci F, Davies A, Fernando I, McGee M, Williams T, Robson C, Hungerford R, Ooi JY, Sverdlov AL, Sanson-Fisher R, Boyle AJ. Investigating the effect of an online enhanced care program on the emotional and physical wellbeing of patients discharged from hospital with acute decompensated heart failure: study protocol for a randomised controlled trial. Digit Health 2024; 10:20552076241256503. doi: 10.1177/20552076241256503. PMID: 38817841
  29. Geenty PD, Gregory AT, Nolan M, Denniss AR, Pepe S, Sverdlov AL#, Thomas L#. Cardio-Oncology—Beyond Anthracyclines and Ejection Fraction. Heart Lung Circ 2024; 33:547–552. https://doi.org/10.1016/j.hlc.2024.05.002. PMID: 38823894
  30. Sverdlov AL, Koczwara B, Cehic DA, Clark RA, Hunt L, Koh ES, Nicholls SJ, Thomas L, Thornton-Benko E, Kritharides L; Clinical Oncology Society of Australia (COSA)–Cardiac Society of Australia and New Zealand (CSANZ) Cardio-Oncology Working Group. When cancer and cardiovascular disease intersect: the challenge and the opportunity of cardio-oncology. Heart Lung Circ 2024; 33:558–563. https://doi.org/10.1016/j.hlc.2023.04.301. PMID: 37321867
  31. Singleton AC, Redfern J, Diaz A, Koczwara B, Nicholls SJ, Negishi K, La Gerche A, Playford D, Conyers R, Cehic DA, Garvey G, Williams TD, Hunt L, Doyle K, Figtree GA, Ngo DTM#, Sverdlov AL#. Integrating cardio-oncology across the research pipeline, policy, and practice in Australia - an ACvA perspective. Heart Lung Circ 2024; 33:564–75. https://doi.org/10.1016/j.hlc.2024.01.011. PMID: 38336544
  32. Balachandran L, Haw TJ, Leong AJW, Croft AJ, Chen D, Kelly C, Sverdlov AL#, Ngo DTM#. Cancer therapies and cardiomyocyte viability: which drugs are directly cardiotoxic? Heart Lung Circ 2024; 33:747–752. https://doi.org/10.1016/j.hlc.2024.01.013. PMID: 38365500
  33. Yu C, Negishi T, Pathan F, Sverdlov A, Thomas L, Shirazi M, Koo CY, Tan LL, Miyazaki S, Negishi K. Rationale and design of the Cessation Of Pharmacotherapy in Recovered Chemotherapy induced cardioToxicity (COP-RCT) – a pilot study. Heart Lung Circ 2024; 33:753–757. doi: 10.1016/j.hlc.2023.10.004. PMID: 37949748
  34. Bennetts J, White J, Croft H, Cooper J, McIvor D, Eadie N, Appay M, Sverdlov AL, Ngo DTM. Pharmacist-Led Medication Management Services: A Qualitative Exploration of Transition-of-Care Cardiovascular Disease Patient Experiences. BMJ Open 2024; 14:e082228. doi: 10.1136/bmjopen-2023-082228. PMID: 38777587
  35. Croft AJ, Kelly C, Chen D, Murtha LA, Haw TJ, Balachandran L, Boyle AJ, Sverdlov AL#, Ngo DTM#. Sex-based differences in short and longer-term diet-induced metabolic heart disease. Am J Physiol Heart Circ Physiol 2024; 326(5):H1219-H1251. doi: 10.1152/ajpheart.00467.2023. PMID: 38363215.
  36. -APS Select Award winner-
  37. Short CE, Rawstorn JC, Jones T, Edbrooke L, Hayes S, Maddison R, Nightingale S, Ismail H, De Boer R, Hegi-Johnson F, Sverdlov AL, Bell R, Halligan I, Denehy L. Evaluating a Remotely delivered Cardio-Oncology Rehabilitation intervention for Breast cancer patients (REMOTE-COR-B): Protocol for a single arm, feasibility trial. JMIR Res Protoc 2024; 13:e53301. doi: 10.2196/53301. PMID: 38578682
  38. Collins NJ, Ngo DTM, Sverdlov AL. New cimlanod trial provides insights into mechanistic effects of vasodilators in heart failure. Eur J Heart Fail 2024; 26(1):152-154. doi: 10.1002/ejhf.3110. PMID: 38124440
  39. Sindone AP, Driscoll A, Audehm R, Sverdlov AL, McVeigh J, Chan WPA, Hickey A, Hopper I, Chang T, Maiorana A, Atherton JJ. Optimising transitional care following a heart failure hospitalisation in Australia. Heart Lung Circ 2024; S1443-9506(24)00193-8. doi: 10.1016/j.hlc.2023.11.029. PMID: 38692982
  40. Litwin SE, Komtebedde J, Seidler T, Borlaug BA, Bruch L, Solomon SD, Eicher J-C, Mazimba S, Khawash R, Sverdlov AL, Hummel SL, Bugger H, Boenner F, Hoendermis E, Cikes M, Demers C, Silva L, van Empel V, Starling R, Penicka M, Cutlip DE, Leon MB, Kitzman DW, van Veldhuisen D, Shah SJ. Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial. Eur J Heart Fail 2024; 26(1):177-189. doi: 10.1002/ejhf.3092. PMID: 37989800
  41. Ray M*, Butel-Simoes LE*, Lombard JM, Nordman IIC, van der Westhuizen A, Collins NJ, Ngo DTM#, Sverdlov AL#. Women’s Cardiovascular Health – The Cardio-Oncologic Jigsaw. Climacteric 2024; 27(1):60-67. https://doi.org/10.1080/13697137.2023.2286382. PMID: 38073542
  42. Fakes K, Williams T, Collins N, Boyle A, Sverdlov AL, Boyes A, Sansom-Fisher R. Preparation for cardiac procedures: a cross-sectional study identifying gaps between outpatients’ views and experiences of patient-centred care. Eur Heart J Qual Care Clin Outcomes 2024; 10(3):235-245. doi: 10.1093/ehjqcco/qcad042. PMID: 37451699
  43. Thornton-Benko E, Koczwara B, Sverdlov AL. Cardio-Oncology - The GP’s Role. Cardiology Today 2023; 13(2): 66-72.
  44. Williams T, Ngo DTM, Sverdlov AL. Examining real world quality of care for Australia’s First Peoples presenting with chest pain. Lancet Reg Health West Pac 2023; 38:100869; https://doi.org/10.1016/j.lanwpc.2023.100869. PMID: 37529487
  45. Teske AJ, Moudgil R, López-Fernández T, Barac A, Brown SA, Deswal A, Neilan TG, Ganatra S, Abdel Qadir H, Menon V, Sverdlov AL, Cheng RK, Makhoul S, Ghosh AK, Szmit S, Zaha V, Addison D, Zhang L, Herrmann J, Chong JH, Agarwala V, Iakobishvili Z, Guerrero P, Yang EH, Leja M, Akhter N, Guha A, Okwuosa T, Carvalho Silva C, Collier P, DeCara P, Bauer B, Lenneman CE, Sadler D. The Global Cardio Oncology Registry (G-COR). Registry design, primary objectives and future perspectives of a multi-center global initiative. Circ Cardiovasc Qual Outcomes 2023; 16(10):e009905. doi: 10.1161/CIRCOUTCOMES.123.009905. PMID: 37702048
  46. Murtha LA, Hardy SA, Mabotuwana NS, Bigland MJ, Bailey T, Raguram K, Liu S, Ngo DT, Sverdlov AL, Tomin T, Birner-Gruenberger R, Hume RD, Iismaa SE, Humphreys D, Patrick R, Chong JJH, Lee RJ, Harvey RP, Graham RM, Rainer PP, Boyle AJ. Fibulin-3 is necessary to prevent cardiac rupture following myocardial infarction. Sci Rep 2023; 13(1):14995. doi: 10.1038/s41598-023-41894-9. PMID: 36939661
  47. Kelly C, Chu M, Untaru R, Assadi-Khansari B, Chen D, Croft AJ, Horowitz JD, Boyle AJ, Sverdlov AL#, Ngo DTM#. Association of circulating plasma Secreted Frizzled-related protein 5 (Sfrp5) levels with cardiac function. J Cardiovasc Dev Dis 2023; 10(7), 274; https://doi.org/10.3390/jcdd10070274. PMID: 37504530
  48. Croft AJ, Kelly C, Chen D, Haw TJ, Sverdlov AL#, Ngo DTM#. Overexpression of mitochondrial catalase within adipose tissue does not confer systemic metabolic protection against diet-induced obesity. Antioxidants 2023; 12(5), 1137. https://doi.org/10.3390/antiox12051137. PMID: 37238003
  49. Williams TD, Kaur A, Warner T, Aslam M, Clark V, Walker R, Ngo DT#, Sverdlov AL#. Cardiovascular outcomes of cancer patients in rural Australia. Front Cardiovasc Med 2023; 10:1144240. doi: 10.3389/fcvm.2023.1144240. PMID: 37180785
  50. Chen D, Untaru R, Stavropoulou G, Assadi-Khansari B, Kelly C, Croft AJ, Sugito S, Collins NJ, Sverdlov AL#, Ngo DTM#. Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE). J Clin Med 2023; 12(8):2790. doi: 10.3390/jcm12082790. PMID: 37109127
  51. Butel-Simoes L*, Haw TJ*, Williams T*, Sritharan S, Gadre P, Herrmann SM, Herrmann J, Ngo DTM#, Sverdlov AL#. Established and Emerging Cancer Therapies and Cardiovascular System: focus on hypertension – mechanisms and mitigation. Hypertension 2023; 80(4):685-710. doi: 10.1161/HYPERTENSIONAHA.122.17947. PMID: 36756872
  52. Litwin SE, Komtebedde J, Hu M, Burkhoff D, Hasenfuß G, Borlaug BA, Solomon SD, Zile MR, Mohan R, Khawash R, Sverdlov AL, Fail P, Chung E, Kaye D, Blair J, Eicher J-C, Hummel SL, Zirlik A, Westenfeld R, Hayward C, Gorter T, Demers C, Shetty R, Lewis GD, Starling R, Patel S, Gupta DK, Morsli H, Penicka M, Cikes M, Gustafsson F, Silvesrty FE, Rowin EJ, Cutlip DE, Leon MB, Kitzman DW, Kleber FX, Shah SJ. Exercise-Induced Left Atrial Hypertension in Heart Failure with Preserved Ejection Fraction. JACC Heart Fail 2023; 11(8 Pt 2):1103-1117. doi: 10.1016/j.jchf.2023.01.030. PMID: 36939661
  53. Lee GA, Aktaa S, Baker E, Gale CP, Yaseen IF, Gulati G, Asteggiano R, Szmit S, Cohen-Solal A, Abdin A, Jurczak W, Garrido Lopez P, Sverdlov AL, Tocchetti GC, Barac A, Parrini I, Zamorano P, Iakobishvili Z, Pudil R, Badimon L, Kirby AM, Blaes AH, Farmakis D, Cuigliano G, Stephens R, Lyon AR, Lopez-Fernandez T. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment. Eur Heart J Qual Care Clin Outcomes 2023; 9(1):1-7. PMID: 36316010
  54. McGee M, Shephard L, Sugito S, Baker D, Brienesse S, Al-Omary M, Nathan-Marsh R, Ngo DTM, Oakley P, Boyle AJ, Garvey G, Sverdlov AL. Mind the Gap, Aboriginal and Torres Strait Islander Cardiovascular Health: A Narrative Review. Heart Lung Circ 2023; 32(2):136-142. doi: 10.1016/j.hlc.2022.09.017. PMID: 36336616
  55. Quirk T, Yao Y, Sverdlov AL, Murch SD. Malignant pericardial effusions: a retrospective look at aetiology and prognosis in a tertiary oncological centre. Asia Pac J Clin Oncol 2023; 19(4):468-472. doi: 10.1111/ajco.13838. Epub 10/08/2022. PMID: 35950292
  56. McGee MJ, Ray M, Brienesse SC, Sritharan S, Boyle AJ, Jackson N, Leitch JW, Sverdlov AL. Remote Monitoring in Heart Failure Patients with Cardiac Implantable Electronic Devices: A Systematic Review and Meta-analysis. Open Heart 2022; 9(2):e002096. doi: 10.1136/openhrt-2022-002096. PMID: 36442906
  57. Nolan MT, Creati L, Koczwara B, Kritharides L, Lynam J, Lyon AR, Negishi K, Ngo DTM, Thomas L, Vardy J, Sverdlov AL. First ESC Cardio-Oncology Guidelines: A Big Leap Forward for an Emerging Specialty. Heart Lung Circ 2022; 31:1563-7. PMID: 36549840
  58. White J, Byles J, Williams T, Untaru R, Ngo DTM, Sverdlov AL. Early access to a cardio-oncology clinic in an Australian context: A qualitative exploration of patient experiences. Cardio-Oncology 2022; 8(1):14. doi: 10.1186/s40959-022-00140-3. PMID: 35945637.
  59. Awan FT, Addison D, Alfraih F, Baratta SJ, Campos RN, Cugliari MS, Goh YT, Ionin VA, Mundnich S, Sverdlov AL, Tam C, Ysebaert L. International Consensus Statement on the Management of Cardiovascular Risk of Bruton's Tyrosine Kinase Inhibitors in CLL. Blood Adv 2022; 6(18):5516-5525. doi: 10.1182/bloodadvances.2022007938. PMID: 35790105
  60. Collins N, Sugito S, Davies A, Boyle A, Sverdlov A, Attia J, Stewart S, Playford D, Strange G. Prevalence and Survival Associated with Pulmonary Hypertension after Mitral Valve Replacement: National Echocardiography Database of Australia study. Pulm Circ 2022; 12(4):e12140. doi: 10.1002/pul2.12140. PMID: 36262467
  61. Sindone AP, De Pasquale CG, Amerena J, Burdeniuk C, Chan WP, Coats AJS, Hare DL, MacDonald PS, Sverdlov A, Atherton JJ. Consensus statement on the current pharmacological prevention and management of heart failure. Med J Aust 2022; 217(4):212-217. doi: 10.5694/mja2.51656. PMID: 35908234
  62. Dee F, Savage L, Leitch JW, Collins N, Loten C, Fletcher P, French J, Weaver N, Watson O, Orvad H, Inder KJ, McIvor D, Williams T, Davies AJ, Attia J, Wiggers J, Sverdlov AL, Boyle AJ. Management of Rural Acute Coronary Syndromes (MORACS) A Randomized Controlled Trial. JAMA Cardiol 2022; 7(7):690-698. doi:10.1001/jamacardio.2022.1188. PMID: 35612860
  63. Chye AM, Nordman IIC, Sverdlov AL. Successful Immune Checkpoint Inhibitor Rechallenge After Immune-Related Pericarditis: Clinical Case Series. Front Cardiovasc Med 2022; 8(1):14. doi: 10.1186/s40959-022-00140-3. PMID: 36017099
  64. Al-Omary MS, Majeed T, Al-Khalil H, Sugito S, Clapham M, Ngo DTM, Attia J, Boyle AJ, Sverdlov AL. Patient characteristics, short and long-term outcomes after incident heart failure admissions in a regional Australian setting. Open Heart 2022; 9(1):e001897. doi: 10.1136/openhrt-2021-001897. PMID: 35641098
  65. Harris M, Egan N, Forder PM, Bateson D, Sverdlov AL, Murphy VE, Loxton D. Patterns of contraceptive use among young Australian women with chronic disease: findings from a prospective cohort study. Reprod Health 2022; 19(1):111. doi: 10.1186/s12978-022-01413-x. PMID: 35525995
  66. Shah SJ, Borlaug BA, Chung ES, Cutlip DE, Debonnaire P, Fail PS, Gao Q, Hasenfuß G, Kahwash R, Kaye DM, Litwin S, Lurz P, Massaro JM, Mohan RC, Ricciardi MJ, Solomon SD, Sverdlov AL, Swarup V, van Veldhuisen DJ, Winkler S, Leon MB. Atrial Shunt Device for Heart Failure with Preserved and Mildly Reduced Ejection Fraction (REDUCE-LAP HF II): A Randomised, Multicentre, Blinded, Sham-Controlled Trial. Lancet 2022; 399(10330):1130-1140. PMID: 35120593
  67. Yu C, Sverdlov AL, Pathan F, Kritharides L, Negishi K. The status of cardio-oncology in Australia in 2021: a nationwide multidisciplinary survey. Intern Med J 2022; 52(2):341-342. PMID: 35187823
  68. Chen D*, Kelly C*, Haw TJ*, Lombard JM, Nordman IIC, Croft AJ, Ngo DTM#, Sverdlov AL#. Heart failure in breast cancer survivors: focus on early detection and novel biomarkers. Curr Heart Fail Rep 2021; 18(6):362-77. doi: 10.1007/s11897-021-00535-w. PMID: 34731413
  69. Ferreira D, Mikhail P, McGee M, Boyle A, Sverdlov A, William M, Jackson N, Barlow M, Leitch J, Collins N, Ford T, Wilsmore B. Investigating the Efficacy of Chest Pressure for Direct Current Cardioversion in Atrial Fibrillation: A Randomised Control Trial Protocol (Pressure-AF). Open Heart 2021; 8(2):e001739. doi: 10.1136/openhrt-2021-001739. PMID: 34556559
  70. Cehic DA, Sverdlov AL, Koczwara B, Emery J, Ngo DTM, Thornton-Benko E. The Importance of Primary Care in CardioOncology. Curr Treat Options Oncol 2021; 22(12):107. doi: 10.1007/s11864-021-00908-2. PMID: 34674055
  71. Ferreira D, Graffen S, Watkins B, Peters B, Lim G, Kamalanathan H, Leitch J, Sverdlov A, Collins N, Boyle A, Davies A. Effects of lockdown on acute coronary syndrome incidence in an area without community transmission of COVID-19. Open Heart 2021; 8:e001692. doi:10.1136/openhrt-2021-001692. PMCID: PMC8219482
  72. Butel-Simoes LE, Ngo DTM, Sverdlov AL. Digital Technologies to Help Delivery of Cardio–Oncology Care. Heart Lung Circ 2021; 30(9):1271-3. PMID: 34219023
  73. Ell P, Martin J, Cehic DA, Ngo DTM, Sverdlov AL. Cardiotoxicity of Radiation Therapy: Mechanisms, Management and Mitigation. Curr Treat Options Oncol 2021; 22 (8):70. https://doi.org/10.1007/s11864-021-00868-7. PMID: 34110500
  74. McGee M, Sugito S, Al-Omary MS, Hartnett D, Senanayake T, Hales K, Majeed T, Ngo DTM, Oakley P, Leitch JW, Sverdlov AL, Boyle AJ. Heart Failure Outcomes in Aboriginal and Torres Strait Islander Peoples in the Hunter New England Region of New South Wales. Int J Cardiol 2021; 334:65-71. doi: 10.1016/j.ijcard.2021.04.001. PMID: 33839176
  75. Sverdlov AL, Collins NJ. Hypertension Editors’ Picks: Pulmonary Hypertension. Hypertension 2021; 77 (1): e1-e10; doi: 10.1161/HYPERTENSIONAHA.120.14379.
  76. Ngo DTM, Williams T, Horder S, Kritharides L, Vardy J, Mandaliya H, Nordman IIC, Lynam J, Bonaventura T, Sverdlov AL. Factors associated with adverse cardiovascular events in cancer patients treated with Bevacizumab. J Clin Med 2020; 9(8), 2664; https://doi.org/10.3390/jcm9082664. PMID: 32824667
  77. Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A, Tocchetti CG, Moslehi J,  Groarke JD, Bergler-Klein J, Khoo V, Tan LT, Anker MS, von Haehling S, Maack C, Pudil R, Barac A,  Thavendirnathan P, Ky B, Neilan TG, Belenkov Y, Rosen SD, Iakobishvili Z, Sverdlov AL, Hajjar LA, Macedo AVS, Manisty C, Ciardiello F, Farmakis D, De Boer RA, Skouri H, Suter TM, Cardinale D,  Witteles RM, Fradley MG, Herrmann J, Cornell RF, Wechelaker A, Mauro MJ, Milojkovic D, de Lavallade H, Ruschitzka F, Coats AJS, Seferovic PM, Chioncel O, Thum T, Bauersachs J, Andres MS, Wright DJ, López-Fernández T, Plummer C, Lenihan D. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a Position Statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society. Eur J Heart Fail 2020; 22(11):1945-1960. doi: 10.1002/ejhf.1920. PMID: 32463967
  78. Untaru R, Chen D, Kelly C, May A, Collins NJ, Leitch J, Attia JR, Proietto AM, Boyle AJ, Sverdlov AL#, Ngo DTM#. Suboptimal Use of Cardioprotective Medications in Patients with a History of Cancer. JACC CardioOncol 2020; 2(2): 312-315. PMID: 34396237
  79. Al-Omary MS, Sugito S, Boyle AJ, Sverdlov AL#, Collins NJ#. Pulmonary Hypertension due to Left Heart Disease: Diagnosis, Pathophysiology and Therapy. Hypertension 2020; 75:1397–1408. PMID: 32336230
  80. Diaz A, Sverdlov AL, Kelly B, Ngo DTM, Bates N, Garvey G. The nexus of cancer and cardiovascular disease for Australia’s First Peoples. JCO Glob Oncol 2020; 6:115-119. PMID: 32031450
  81. Croft AJ, Ngo DTM, Sverdlov AL. Anthracycline-induced cardiotoxicity: Time to focus on cardioprotection again. Heart Lung Circ 2019; 28(10):1454-1456. PMID: 31495502
  82. Luptak I, Qin F, Sverdlov AL, Pimentel DR, Panagia M, Croteau D, Siwik DA, Bachschmid MM, He H, Balschi JA, Colucci WS. Energetic dysfunction is mediated by mitochondrial ROS and precedes structural remodeling in metabolic heart disease. Antioxid Redox Signal 2019; 31(7):539-549. PMID: 31088291
  83. Ezad S, Khan AA, Cheema H, Ashraf A, Ngo DTM, Sverdlov AL#, Collins NJ#. Ibrutinib Related Atrial Fibrillation – A Single Centre Australian Experience. Asia Pac J Clin Oncol 2019; 15(5):e187-e190. PMID: 31250562
  84. McGee M, Sugito S, Sverdlov AL. Cardiovascular Outcomes in Indigenous Australians: A National Gap. Heart Lung Circ 2019; 28:825-826. PMID: 31076127
  85. Ngo DTM*, Sverdlov AL*, Karki S, Macartney-Coxson D, Stubbs RS, Farb MG, Carmine B, Hess DT, Colucci WS, Gokce N. Oxidative Modifications of Mitochondrial Complex II are associated with insulin resistance of visceral fat in obesity. Am J Physiol Endocrinol Metab 2019; 316(2):E168-E177. PMID: 30576243
  86. Gopal DM, Ayalon N, Wang YC, Siwik D, Sverdlov A, Donohue C, Perez A, Downing J, Apovian C, Silva V, Panagia M, Kolachalama V, Ho JE, Liang CS, Gokce N, Colucci WS. Galectin-3 is Associated with Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients. J Am Heart Assoc 2019; 8(7):e011100. PMID: 30929550
  87. Murtha LA*, Morten M*, Schuliga MJ*, Mabotuwana NS, Hardy SA, Waters DW, Burgess JK, Ngo DTM, Sverdlov AL, Knight DA, Boyle AJ. The role of pathological aging in cardiac and pulmonary fibrosis. Aging Dis 2019; 10(2):419-428. PMID: 31011486
  88. Brienesse SC, Sverdlov AL. Premature Ventricular Complexes: Benign, Pathogenic or Just a Marker of Myocardial Disease? Heart Lung Circ 2019; 28(3):351-353. PMID: 30712655
  89. Al-Omary MS, Mcivor D, Sverdlov AL. Predicting Events in Heart Failure Patients: An Ongoing Challenge. Heart Lung Circ 2019; 28(2):195-197. PMID: 30654943
  90. Ezad S, Al-Omary MS, Davies AJ, Sverdlov AL, Boyle AJ. Heart Failure Admissions Following ST Segment Elevation Myocardial Infarction. Aust J Rural Health 2019; 27(1):99-100. PMID: 30701609
  91. Luptak I, Sverdlov AL, Panagia M, Qin F, Pimentel DR, Croteau D, Siwik DA, Ingwall JS, Bachschmid MM, Balschi JA, Colucci WS. Decreased ATP Production and Myocardial Contractile Reserve in Metabolic Heart Disease. J Mol Cell Cardiol 2018; 116:106-114. PMID: 29409987
  92. Efird JT, Jindal C, Kiser AC, Akhter SA, Crane PB, Kypson AP, Sverdlov AL, Davies SW, Kindell LC, Anderson EJ. Increased Atrial Fibrillation Risk among Coronary Artery Bypass Graft (CABG) Patients receiving Nitrates and Antiplatelet Agents. J Int Med Res 2018; 46(8):3183-3194. PMID: 29808744
  93. Al-Omary MS, Khan AA, Davies AJ, Fletcher PJ, McIvor D, Bastian B, Oldmeadow C,  Sverdlov AL, Attia JR, Boyle AJ. Outcomes Following Heart Failure Hospitalization in a Regional Australian Setting Between 2005-2014. ESC Heart Fail 2018; 5(2):271-278. PMID: 29265710
  94. Amarasekera AT, Assadi-Khansari B, Liu S, Black M, Dymmott G, Rogers N, Sverdlov AL, Horowitz JD, Ngo DT. Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adults. PLoS One 2017; 12(5):e0174435. PMID: 28489857
  95. Patchett ND, Pawar S, Sverdlov A, Miller EJ. Does Improved Technology in SPECT Myocardial Perfusion Imaging Reduce Downstream Costs? An Observational Study. Int J Radiol Imaging Technol 2017; 3:023.
  96. Sverdlov AL, Ngo DT. Response to the letter to editor: Galectin-3 and atrial fibrillation. Int J Cardiol 2017; 229:2. PMID: 27956319
  97. Sverdlov AL, Figtree GA, Horowitz JD, Ngo DT. Interplay between oxidative stress and inflammation in cardiometabolic syndrome. Mediators Inflamm 2016; 2016:8254590. PMID: 27563174
  98. Chen D, Procter N, Goh V, Liu S, Chua SJ, Assadi-Khansari B, Horowitz JD, Sverdlov AL, Ngo DT. New onset atrial fibrillation is associated with elevated Galectin-3 levels. Int J Cardiol 2016; 223:48-49. PMID: 27529590
  99. Amarasekera AT, Sverdlov AL, Horowitz JD, Ngo DT. Elevated parathyroid hormone predicts high asymmetric dimethylarginine (ADMA) concentrations in obese diabetic patients. Diabetes Metab 2016; 42(5):378-381. PMID: 27286738
  100. Sverdlov AL, Elezaby A, Qin F, Behring JB, Luptak I, Calamaras T, Siwik DA, Miller EJ, Liesa M, Shirihai OS, Pimentel DR, Cohen RA, Bachschmid MM, Colucci WS. Mitochondrial reactive oxygen species mediate cardiac structural, functional and mitochondrial consequences of diet-induced metabolic heart disease. J Am Heart Assoc 2016; 5(1). pii: e002555. PMID: 26755553
  101. Horowitz JD, Chong CR, Ngo DT, Sverdlov AL. Effects of acute hyperglycaemia on cardiovascular homeostasis: Does a spoonful of sugar make the flow-mediated dilatation go down? J Thorac Dis 2015; 7(12): E607-11. PMID: 26793371
  102. Yao C, Behring JB, Shao D, Sverdlov AL, Whelan SA, Elezaby A, Yin X, Siwik DA, Seta F, Costello CE, Colucci WS, Cohen RA, Matsui R, McComb ME, Bachschmid MM. Overexpression of catalase diminishes oxidative cysteine modifications of cardiac proteins. PLoS One 2015; 10(12): e0144025. PMID: 26642319
  103. Miller EJ, Calamaras T, Elezaby A, Sverdlov A, Qin F, Luptak I, Wang K, Su X, Vijay A, Croteau D, Bachschmid M, Cohen RA, Walsh K, Colucci WS. Partial LKB1 deficiency promotes diastolic dysfunction, de novo systolic dysfunction, apoptosis and mitochondrial dysfunction with dietary metabolic challenge. J Am Heart Assoc 2015; 5(1): pii: e002277. PMID: 26722122
  104. Elezaby A, Sverdlov AL, Tu VH, Soni K, Luptak I, Qin F, Liesa M, Shirihai OS, Rimer J, Schaffer JE, Colucci WS, Miller EJ. Mitochondrial Remodeling in Mice with Cardiomyocyte-Specific Lipid Overload. J Mol Cell Cardiol 2015; 79:275-283. PMID: 25497302
  105. Sverdlov AL, Elezaby A, Behring JB, Bachschmid MM, Luptak I, Tu VH, Siwik DA, Miller EJ, Liesa M, Shirihai OS, Pimentel DR, Cohen RA, Colucci WS. High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex II. J Mol Cell Cardiol 2015; 78:165-173. PMID: 25109264
  106. Sverdlov AL, Ngo DTM, Chan WPA, Chirkov YY, Horowitz JD. Aging of the nitric oxide system: Are we as old as our NO? J Am Heart Assoc 2014; 3(4) pii: e000973. PMID: 25134680
  107. Procter NEK, Chong CR, Sverdlov AL, Chan WPA, Chirkov YY, Horowitz JD. Aging of platelet nitric oxide signaling: pathogenesis, clinical implications, and therapeutics. Semin Thromb Hemost 2014; 40(6):660-8. PMID: 25173501
  108. Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, Govender P, Ruberg FL, Miller EJ. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2014; 21(5):925-39. PMID: 24879453
  109. Chong CR, Chan WP, Nguyen TH, Liu S, Procter NE, Ngo DT, Sverdlov AL, Chirkov YY, Horowitz JD. Thioredoxin-interacting protein: Pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes. Cardiovasc Drug Ther 2014; 28(4):347-60. PMID: 25088927
  110. Sverdlov AL, Chan WPA, Procter NE, Chirkov YY, Ngo DTM, Horowitz JD. Reciprocal regulation of NO signaling and TXNIP expression in humans: impact of aging and ramipril therapy. Int J Cardiol 2013; 168(5):4624-30. PMID: 23958415
  111. Dautov RF, Ngo DTM, Licari G, Liu S, Sverdlov AL, Ritchie RH, Kemp-Harper BK, Horowitz JD, Chirkov YY. The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness. Nitric Oxide 2013; 35:72-78. PMID: 24012721
  112. Nguyen TH, Neil CJ, Sverdlov AL, Ngo DT, Chan WP, Heresztyn T, Chirkov YY, Tsikas D, Frenneaux MP, Horowitz JD. Enhanced NO signaling in patients with Takotsubo Cardiomyopathy: short-term pain, long-term gain? Cardiovasc Drug Ther 2013; 27(6):541-7. PMID: 23921835
  113. Chan WP, Ngo DT, Sverdlov AL, Rajendran S, Stafford I, Heresztyn T, Chirkov YY, Horowitz JD. Premature ageing of cardiovascular/platelet function in polycystic ovarian syndrome. Am J Med 2013; 126(7):e1-7. PMID: 23688663
  114. Maher AR, Arif S, Madhani M, Abozguia K, Ahmed I, Fernandez BO, Feelisch M, O'Sullivan AG, Christopoulos A, Sverdlov AL, Ngo D, Dautov R, James PE, Horowitz JD, Frenneaux MP. Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite. Br J Pharmacol 2013; 169(3):659-70. PMID: 23472879
  115. Ngo DT, Horowitz JD, Sverdlov AL. Heart failure – a corin deficient state? Hypertension 2013; 61:284-5. PMID: 23232647
  116. Sverdlov AL*, Ngo DTM*, Chan WPA, Chirkov YY, Gersh BJ, McNeil JJ, Horowitz JD. Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics. Eur Heart J 2012; 33(19):2419-25. PMID: 22771677
  117. Ngo DT*, Sverdlov AL*, Horowitz JD. Prevention of aortic valve stenosis: a realistic therapeutic target? Pharmacol Ther 2012; 135(1):78-93. PMID: 22516738
  118. Neil C, Nguyen TH, Kucia A, Crouch B, Sverdlov A, Chirkov Y, Mahadavan G, Selvanayagam J, Dawson D, Beltrame JF, Zeitz C, Unger S, Redpath T, Frenneaux M, Horowitz J. Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac magnetic resonance imaging. Heart 2012; 98(17):1278-84. PMID: 22791656
  119. Sverdlov AL, Ngo DT, Horowitz JD. Redefining the natural history of calcific aortic stenosis: lessons from Laennec. J Intern Med 2012; 271(6):569-72. PMID: 22324298
  120. Neil CJ, Nguyen TH, Sverdlov AL, Chirkov YY, Chong CR, Stansborough J, Beltrame JF, Kucia AM, Zeitz CJ, Frenneaux MP, Horowitz JD. Can we make sense of Tako-Tsubo cardiomyopathy? An update on pathogenesis, diagnosis and natural history. Expert Rev Cardiovasc Ther 2012; 10(2):215-221. PMID: 22292877
  121. Sverdlov AL, Ngo DT, Horowitz JD. Pathogenesis of aortic sclerosis: association with low BMI, tissue nitric oxide resistance, but not systemic inflammatory activation. Am J Cardiovasc Dis 2012; 2(1):43-9. PMID: 22254213
  122. Sverdlov AL, Ngo DT, Chapman MJ, Akbar Ali O, Chirkov YY, Horowitz JD. Pathogenesis of aortic stenosis: not just a matter of wear and tear. Am J Cardiovasc Dis 2011; 1(2):185-199. PMID: 22254198
  123. Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, Stansborough J, Beltrame JF, Selvanayagam JB, Zeitz CJ, Struthers AD, Frenneaux MP, Horowitz JD. N-terminal pro brain natriuretic protein levels in Takotsubo cardiomyopathy. Am J Cardiol 2011; 108(9):1316-21. PMID: 21871590
  124. Ngo DTM, Chan WP, Rajendran S, Heresztyn T, Amarasekera A, Sverdlov AL, O’Loughlin PD, Morris HA, Chirkov YY, Norman RJ, Horowitz JD. Determinants of insulin responsiveness in young women: impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide 2011; 25(3):326-30.  PMID: 21741493
  125. Sverdlov AL, Ngo DT, Nightingale AK, Rajendran S, Mishra K, Heresztyn T, Ritchie RH, Marwick TH, Frenneaux MP, Horowitz JD. The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload. Nitric Oxide 2011; 25(1): 41-46. PMID: 21550414
  126. Ling LH, Chik WWB, Averbuj PA, Pati PK, Sverdlov AL, Ngo DTM, Morris RG, Sallustio BC, Horowitz JD. Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state of perhexiline. Ther Drug Monit 2011; 33 (2):251-6. PMID: 21383654
  127. Ngo DTM, Stafford I, Sverdlov AL, Qi W, Wuttke RD, Zhang Y, Kelly DJ, Weedon H, Smith MD, Kennedy JA, Horowitz JD. Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations. Br J Pharmacol 2011; 162 (3): 722-32. PMID: 20958293
  128. Nightingale AK, Sverdlov AL, Rajendran S, Mishra K, Heresztyn T, Ngo DTM, Horowitz JD. Lack of association between aortic sclerosis and left ventricular hypertrophy in elderly subjects. Int J Cardiol 2011; 150:33-8. PMID: 20236713
  129. Chirkov YY, De Sciscio M, Sverdlov AL, Leslie S, Sage PR, Horowitz JD. Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure. Cardiovasc Drugs Ther 2010; 24(2):131-7. PMID: 20490904
  130. Horowitz JD, Chirkov YY, Kennedy JA, Sverdlov AL. Modulation of myocardial metabolism: an emerging therapeutic principle. Curr Opin Cardiol 2010; 25(4):329-334. PMID: 20535068
  131. Ngo DTM, Sverdlov AL, McNeil JJ, Horowitz JD. Does vitamin D modulate ADMA and CRP concentrations? Am J Med 2010; 123:335-341. PMID: 20362753
  132. Ngo DTM, Sverdlov AL, McNeil JJ, Horowitz JD. Correlates of arterial stiffness in an ageing population: role of asymmetric dimethylarginine. Pharmacol Res 2009; 60(6):503-7. PMID: 19559793
  133. Ngo DTM, Sverdlov AL, Willoughby SR, Nightingale AK, Chirkov YY, McNeil JJ, Horowitz JD. Determinants of occurrence of aortic sclerosis in an aging population. JACC Cardiovasc Imaging 2009; 2:919-927. PMID: 19679278
  134. Sverdlov AL, Taylor K, Elkington AG, Zeitz CJ, Beltrame JF. Cardiac MRI identifies the elusive perivalvular abscess. Circulation 2008; 118:e1-e3. PMID: 18591443
  135. Ngo DTM, Stafford I, Kelly DJ, Sverdlov AL, Wuttke RD, Weedon H, Nightingale AK, Rosenkranz AC, Smith MD, Chirkov YY, Kennedy JA, Horowitz JD. Vitamin D2 supplementation induces development of aortic stenosis in rabbits: interactions with endothelial function and thioredoxin-interacting protein. Eur J Pharmacol 2008; 590:290-6. PMID: 18585377
  136. Chan WPA, Sverdlov AL, Horowitz JD. Management of the metabolic syndrome in cardiovascular disease. Curr Treat Options Cardiovasc Med 2008; 10:27-38. PMID: 18325305